Furthermore, increased endothelin-1 (ET-1) levels in COPD patients, especially during exacerbations, contribute to pulmonary hypertension by promoting vasoconstriction and vascular remodeling [30,31,32]. This evidence concerns the gene EDN1 and pulmonary arterial hypertension.